Status:
COMPLETED
Idiopathic Pulmonary Fibrosis Registry for Future Studies
Lead Sponsor:
Ohio State University
Conditions:
Lung Disease, Interstitial
Idiopathic Pulmonary Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
To establish a registry of patients for future studies of Inflammation in Interstitial Lung Disease/Idiopathic Pulmonary Fibrosis.
Detailed Description
To establish a framework in which biologic samples and physiologic measures from patients with IPF can be longitudinally collected and evaluated. Having a bank of samples that are correlated with phys...
Eligibility Criteria
Inclusion
- any patient referred to the Interstitial Lund Disease clinic who is undergoing evaluation and or treatment for a new diagnosis of ILD. This can include patients referred for presumed pulmonary fibrosis/interstitial pneumonitis (IPF, UIP, NSIP), sarcoidosis, hypersensitivity pneumonitis, cryptogenic organising pneumonia, drug-induced, or other idiopathic ILDs.
Exclusion
- pregnancy
- inability to follow study requirements
Key Trial Info
Start Date :
December 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 10 2015
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00815711
Start Date
December 1 2008
End Date
June 10 2015
Last Update
November 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University
Columbus, Ohio, United States, 43210